Abstracts

AUGUST 27

Days
:
Hrs
:
Min
:
Sec

Abstract Submission

The IFRUE Scientific Committee invites you to submit abstracts to the Integrating Functional Reconstructive Urology & Endourology (IFRUE 2026) conference, being held in Denver, CO, August 27-30, 2026. All urology specialists are strongly encouraged to share their scientific work.

Timeline

April 8, 2026	Abstract Submission Open
June 26, 2026	Abstract Submission Close (Abstract site closes at 11:59pm MST)
June 30, 2026	Abstract Begins
July 20, 2026	Abstract Ends
Late-July	Abstract Notifications Sent

Be sure to carefully review all submission guidelines in advance.

Procedure
All abstracts mustt be submitted through the IFRUE Abstract Submission Form. Abstracts are approved for presentation and inclusion in the annual scientific program at the recommendation of the 2025 Scientific Committee. The submitting author will receive an email confirming receipt of the abstract. Please notify your co-authors that the confirmation was received.

Disclosure and Funding
Disclosures for ALL presenting and submitting authors are required within the submission form. Any external funding of the study or grants must be declared or stated as NONE.

Submission Format

The recommended abstract length is at least 300 words but not more than 600 words, excluding the title and authors’ names. Abstract title should be descriptive (200 characters or less). The abstract text must be anonymous. i.e., without any authors’ or institutions’ names. Do not include the name of the hospital, university or city. All abstract identification details, references, ethical approval, and disclosures will be taken separately during the online submission process and merged with the abstract text after review.

Images, figures, graphs and tables can be uploaded with a maximum total of 2 per abstract. Studies must not be split into multiple abstracts. This could lead to each abstract being downgraded. Preliminary Data will be considered.

Abstract Entry:

Hypothesis/aims of study
Study design, materials, and methods
Results
Interpretation of results
Concluding message

Abstract Types:

Pure and Applied Science / Translational
Clinical

Abstract Categories:

Female Stress Urinary Incontinence (SUI), Pelvic Organ Prolapse
Interstitial Cystitis/Pelvic Pain, Pelvic Floor Disorders, Infection
Lower Urinary Tract Stricture/Fistula
Male Lower Urinary Tract Symptoms (LUTS) / Voiding Dysfunction / BPH
Male Stress Urinary Incontinence (Post Prostatectomy Incontinence
Neurourology
Overactive Bladder, Neuromodulation
Sexual Dysfunction
Upper Urinary Tract Stricture

Video Abstract

Maximum size is 120MB with allowed video types of .mov and .mp4. Video length cannot exceed 8 minutes. Digital video presentations that are longer than 8 minutes will automatically be rejected.

All digital videos must be recorded in English and may have some sound however, music is not required. The opening frames of the video presentation must begin with the exact title and include the authors’ names.

Submissions of exceedingly commercial presentations are discouraged, and such submissions are less likely to be accepted for presentation. Submissions funded by commercial companies must be identified in a disclaimer at the start of the presentation and disclosed upon submission.

Presentation Materials

Presentation material instructions will be provided upon notification of abstract’s acceptance. The IFRUE Scientific Committee will decide on the final presentation category for each abstract.

All accepted abstracts will be published on the IFRUE website exactly as submitted. Podium presentations will be published in an open-access journal or digital media. Unpublished abstracts previously presented at other meetings may be considered.

IFRUE is not responsible for the content of each presentation, which does not represent IFRUE’s opinion.

If you have any abstract-related questions, please reach out to Brittany Fermo at bfermo@veritasamc.com.